Evolent Health Inc (STU:9EH)
€ 13 -1.5 (-10.34%) Market Cap: 1.62 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 1.68 GF Score: 72/100

Evolent Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 02:10PM GMT
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good morning. My name is Lisa Gill, and I'm the health care technology and distribution analyst of JPMorgan. This morning it is with great pleasure that I introduce Evolent Health. With us this morning, we have CEO, Seth Blackley; as well as CFO, John Johnson. They'll make some opening remarks and present their slides, and then we'll come back for a Q&A session. Let me turn it over to Seth.

Seth Barrie Blackley
Evolent Health, Inc. - Co-Founder, CEO & Director

All right. Great. Thank you, Lisa. Welcome to everybody. I hope you and your families are staying healthy. I'm joined today by John Johnson, our CFO. And as we dive into the materials, I'll just say that we feel that Evolent is at an inflection point, we believe we're continuing to accelerate execution against the plan that we laid out at IR Day a couple of months ago, and we have some exciting news to share in that regard later

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot